Fillerworld Logo Search
NEXT day delivery available - 3pm cut off NEXT day delivery available - 3pm cut off
Worldwide shipping available Worldwide shipping available
Free standard UK delivery on orders over £100 Free standard UK delivery on orders over £100

Cheek Filler: A UK Practitioner's Guide

This article is intended for qualified aesthetic practitioners (doctors, dentists, nurses and other appropriately trained prescribers and injectors). It is not patient advice.

Cheek filler is one of the most requested treatments in UK clinics, and one of the easiest to get subtly wrong. A well-placed midface treatment can support the lower eyelid, soften the nasolabial area and improve how the whole face carries light. Poorly planned, it produces the overfilled, rounded "pillow face" that patients increasingly want to avoid. This guide covers the anatomy, product selection, needle versus cannula decisions, marking, volumes and risk management that matter most when you plan cheek treatments.

Why the midface matters more than the cheekbone

Many patients ask for "cheekbones", but the more useful clinical question is what the midface has lost and where. Volume change in the cheek is rarely uniform. It involves deflation and descent of distinct fat compartments, bony remodelling of the maxilla and orbital rim, and changing support from the retaining ligaments.

The classic description of these compartments comes from Rohrich and Pessa's cadaver work, The Fat Compartments of the Face (Plastic and Reconstructive Surgery, 2007). It showed that facial fat is partitioned into separate superficial and deep compartments rather than forming one confluent layer. In practice, that means restoring a deep medial cheek compartment behaves very differently from adding product superficially over the zygoma.

Key structures to keep in mind

  • Deep medial cheek fat and suborbicularis oculi fat (SOOF): deep support for the lid-cheek junction and anterior projection.
  • Zygomatic arch and body: lateral structure and width; usually treated supraperiosteally.
  • Zygomatic ligament (McGregor's patch): a firm retaining point that helps explain why some patients develop malar bags or festoons that filler may worsen.
  • Infraorbital foramen: typically found roughly in line with the mid-pupillary line below the orbital rim. Map it before you inject.
  • Facial and angular artery course and the transverse facial artery: these vary between patients, so treat any surface landmark as a guide only.

Assessment: lateral or medial, lift or projection?

Before choosing a product, decide what the face needs. A useful way to frame it is to separate three goals that patients often lump together.

Lateral support along the zygomatic arch gives width and a subtle lifting vector, and often improves the lower face indirectly. Anterior projection over the medial cheek restores fullness lost with age and softens the tear trough-cheek transition. Contour definition, the sculpted "high cheekbone" look, uses small boluses at the apex and is the area most prone to overcorrection.

Assess the patient at rest, smiling and from oblique and profile views. Look at skin thickness, the presence of malar oedema or festoons, how prominent the zygoma already is, and whether lower-eyelid hollowing would be better addressed by restoring the cheek first. Photograph from standardised angles and record your findings. This feeds directly into consent and your clinical notes.

Choosing the best filler for cheeks

There is no single best filler for cheeks. The right product depends on depth, the amount of lift needed, skin thickness and your technique. In general, midface work calls for gels with higher elasticity (G′) and cohesivity that hold shape under pressure, particularly for supraperiosteal placement. Softer, more flexible gels suit superficial blending or thin-skinned areas near the lid-cheek junction.

Products commonly selected for the midface include:

  • High-lift, firm gels for deep bolus placement on bone, such as Restylane Volyme with Lidocaine or Restylane Lyft, both commonly chosen for midface volume and contour.
  • Cohesive volumising gels that integrate well in the deep fat, such as Belotero Volume with Lidocaine, often used with a cannula across the medial cheek.
  • Dynamic, resilient gels such as Teosyal RHA 4, designed to adapt to facial movement in deeper planes.

Always check each product's instructions for use for its indicated depth, area and maximum volumes, and use what you have been trained on. You can compare options across brands in our cheek volume filler collection.

Cheek filler injection points and marking

Marking is where planning becomes technique. With the patient upright, many practitioners start by drawing a line from the lateral canthus to the oral commissure and a second from the tragus (or the inferior border of the nasal ala) towards the lateral canthus. The intersections help divide the midface into zones and keep apical injections lateral and above the line where projection looks natural.

Common cheek filler injection points include:

  1. Zygomatic arch: two or three small supraperiosteal boluses along the arch for lateral support.
  2. Zygomatic eminence (apex): one deep bolus at the highest point of the malar prominence, usually in the upper-outer quadrant formed by your marking lines.
  3. Anteromedial cheek: deep placement in the deep medial cheek fat, often by cannula from a lateral entry point, to restore anterior projection.
  4. Submalar area: conservative, usually cannula-led subcutaneous placement where hollowing is significant. Avoid this zone in patients whose faces are already full.

Mark the infraorbital foramen and stay well clear of the orbital rim with deep needle boluses. Note any asymmetry before treatment. Most faces have some, and patients will notice it afterwards if you have not pointed it out first.

Needle or cannula for cheek filler?

Both have a place, and many experienced injectors combine them.

A needle (often 27G or 25G, depending on the product) allows precise supraperiosteal boluses on the zygoma, where accuracy of depth matters and the bone gives a firm end point. Aspiration before injecting is widely practised, although it is not a reliable safety test on its own, and slow, low-pressure injection of small aliquots remains essential.

A blunt cannula (commonly 22G or 25G) is useful for the anteromedial and submalar cheek. It allows fanning across a wider area from a single entry point, often with less bruising. A cannula lowers the risk of intravascular injection but does not remove it, particularly with finer gauges. If you are choosing between gauges and lengths, our cannula buying guide covers the trade-offs in detail, and you can browse the full cannula range.

1ml vs 2ml cheek filler: planning volume

Patients often arrive asking for a fixed amount, typically 1ml or 2ml. Volume should follow the assessment, not the other way round. A young patient seeking subtle lateral definition may need well under 1ml in total. An older patient with marked midface deflation may need more, ideally spread across staged appointments.

Staging has real advantages. It lets tissue settle, gives you a chance to reassess integration and swelling, and reduces the risk of overcorrection. Many practitioners build cheek volume over two sessions a few weeks apart rather than placing a large volume at once. Whatever you plan, record the product, batch number, volume and site for each injection.

Cheek filler to lift jowls: managing expectations

Lateral midface support can improve the appearance of the lower face and jawline in some patients by changing the lifting vector, but it will not correct significant jowling or skin laxity on its own. Be clear about this during consultation. Where laxity is the main issue, combined approaches or referral may be more appropriate than adding volume.

Risks and complication readiness

The midface carries a real risk of vascular compromise, especially near the infraorbital and angular arteries and in the medial cheek close to the nasolabial region. Other complications include bruising, oedema, nodules, delayed-onset inflammatory reactions, malar oedema and filler migration.

Practical safeguards include:

  • Know the danger zones and accept that arterial anatomy varies.
  • Inject slowly, at low pressure, in small aliquots, and keep the tip moving when you work superficially.
  • Watch continuously for blanching, livedo, disproportionate pain or visual symptoms.
  • Keep an up-to-date, in-date emergency kit and a written protocol in the room, and make sure the whole team knows where both are.
  • Follow recognised guidance such as the Aesthetic Complications Expert Group's guideline for the management of HA filler-induced vascular occlusion, and make sure you can access a prescriber promptly if you are not one yourself.

Your consent conversation should cover these risks in plain language, as well as the expected longevity, the possibility of needing further sessions, and the option of dissolving the product. Document it fully. Our guide to aesthetic insurance explains why your notes and protocols matter if a claim ever arises.

Aftercare and review

Give written aftercare advice: avoid pressing or massaging the area unless instructed, avoid strenuous exercise, saunas and heavy facial pressure for the period your protocol specifies, and contact the clinic immediately if pain, skin colour changes or visual disturbance develop. Book a review, commonly at around two weeks, to assess symmetry and integration once initial swelling has settled.

Frequently asked questions

How long does cheek filler last?

Longevity varies with the product, the depth of placement, the treated area and individual metabolism. Manufacturers' data for midface HA fillers typically describe results lasting from several months to more than a year, so check the specific product's instructions for use and set expectations on that basis rather than quoting a single figure.

What are the downsides of cheek filler?

The main concerns are overcorrection and an unnatural result, swelling and bruising, malar oedema, nodules, migration and, most seriously, vascular occlusion. Careful assessment, conservative volumes, staged treatment and complication readiness reduce these risks but cannot eliminate them.

Where should you never inject filler in the cheek?

There is no universal "never" map, but practitioners take particular care around the infraorbital foramen, the medial cheek near the course of the angular artery, and the area directly beneath the orbital rim. Patients with existing malar bags or festoons are often poor candidates for filler in the upper cheek, as it can make swelling worse.

Is a cannula safer than a needle for cheek filler?

A blunt cannula is generally considered to lower the risk of intravascular injection and bruising, particularly in the medial and submalar cheek. It does not remove the risk. Many practitioners still use a needle for precise supraperiosteal boluses on the zygoma and a cannula for broader deep or subcutaneous work.

How much cheek filler does a patient need?

It depends on the assessment. Some patients need less than 1ml for subtle definition, while others with marked deflation need more, ideally spread over staged sessions. Base the plan on facial analysis and the product's IFU rather than a fixed syringe count.

Conclusion

Good cheek filler work starts with anatomy and assessment, not with the syringe. Decide whether the face needs lateral support, anterior projection or contour, choose a product with the right rheology for the depth, mark carefully and stay conservative. Combine that with solid consent, clear documentation and a tested complication protocol, and you can deliver midface results that look natural and age well. When you are ready to stock up, explore our cheek volume fillers and cannulas.

Stay in the Glow!

Subscribe for Exclusive Deals & the Latest Aesthetic Trends

Basket
Orders placed before 3PM will be dispatched the same day. Products For Professional Use Only.